Microba currently offers a direct-to-consumer gut microbiome profile product and plans to release additional products for clinical and research use cases.
Two recent publications suggest that DeepVariant's machine learning is far superior to traditional methods of variant calling, especially with hardware accelerators.
The STRIDES program aims to establish industry partnerships to provide NIH researchers access to cost-effective computational infrastructure, tools, and services.
At HIMSS18, Eric Schmidt announced a new healthcare API for Google Cloud and explored how predictive analytics might change medical care and research for the better.
WuXi's data analysis tools will be hosted on Google's Cloud marketplace while Google's genomics and research tools will be integrated with WuXi's platform.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
